Oscotec

Oscotec is a clinical stage drug discovery and development company. Its clinical pipeline consists of targeted therapeutics in immunology and oncology. The company provides lazertinib, an epidermal growth factor receptor (EGFR) inhibitor designed for lung cancers. In addition, Oscotec develops SKI-G-801, a selective FLT3/AXL inhibitor for acute myelogenous leukemia (AML) as well as other solid tumors.